Peripheral thermal responses in normal and cold-sensitive individuals to sublingual Glyceryl Trinitrate (GTN)
© Hope et al.; 2015
Published: 14 September 2015
Non-freezing cold injury (NFCI) is caused by prolonged exposure of the extremities to cold. The long-term sequelae of NFCI, include cold-sensitivity and pain. The cold sensitivity is characterised by a reduction in basal skin blood flow and augmented vasoconstriction during cold exposure. We tested the hypothesis that sublingual GTN would increase blood flow in the peripheral microcirculation during and after a mild cold challenge in individuals who had not been diagnosed with NFCI, but were cold-sensitive.
In air at 30 °C, seven control and six cold-sensitive participants undertook 12 min of gentle exercise prior to immersing their right foot (protected by a thin plastic bag) into 15 °C water for 2 min, followed by 10 min of spontaneous rewarming. Two minutes prior to immersion, participants were given either 400 µg GTN or placebo sublingually in a single-blinded, counter-balanced order. Toe pad skin temperature (Tsk) and blood flow (SkBF) were measured using infrared thermography and laser Doppler flowmetry respectively.
In the placebo condition, Tsk was significantly lower in Cold-sensitive participants compared to controls throughout the test (P < 0.001) as was SkBF (P < 0.05).
We accept our hypothesis that impairment in the vasodilatory response seen in individuals with cold-sensitivity can be overcome by the use of GTN, an endothelial-independent nitric oxide donor, and thereby improve the rewarming of cooled peripheral tissues.
Individuals with cold-sensitivity show increased vasoconstrictory tone, both at rest and during warming after a cold stimulus, compared to controls. The use of GTN to overcome this implies an abnormal endothelium and nitric oxide pathway in this condition.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.